 |
Pilocarpine |
|---|---|
| Trade Name | Salagen |
| Orphan Indication | Xerostomia induced by radiation therapy for head and neck cancer |
| USA Market Approval | USA |
| USA Designation Date | 1990-09-24 00:00:00 |
| Sponsor | MGI Pharma, Inc.;5775 West Old Shakopee Rd., Suite 100;Bloomington, Minnesota, 55437 |
